Mesoblast Ltd (MESO)
11.32
-0.38
(-3.25%)
USD |
NASDAQ |
Nov 14, 16:00
10.50
-0.82
(-7.24%)
After-Hours: 19:49
Mesoblast Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 1.388B |
| November 12, 2024 | 1.188B |
| November 11, 2024 | 1.163B |
| November 08, 2024 | 1.100B |
| November 07, 2024 | 1.038B |
| November 06, 2024 | 1.049B |
| November 05, 2024 | 1.053B |
| November 04, 2024 | 1.004B |
| November 01, 2024 | 1.020B |
| October 31, 2024 | 1.009B |
| October 30, 2024 | 1.058B |
| October 29, 2024 | 1.086B |
| October 28, 2024 | 1.092B |
| October 25, 2024 | 1.031B |
| October 24, 2024 | 1.042B |
| October 23, 2024 | 1.122B |
| October 22, 2024 | 1.129B |
| October 21, 2024 | 1.154B |
| October 18, 2024 | 1.189B |
| October 17, 2024 | 1.186B |
| October 16, 2024 | 1.126B |
| October 15, 2024 | 1.150B |
| October 14, 2024 | 1.186B |
| October 11, 2024 | 1.203B |
| October 10, 2024 | 1.117B |
| Date | Value |
|---|---|
| October 09, 2024 | 1.101B |
| October 08, 2024 | 1.142B |
| October 07, 2024 | 1.192B |
| October 04, 2024 | 1.286B |
| October 03, 2024 | 1.142B |
| October 02, 2024 | 1.052B |
| October 01, 2024 | 996.04M |
| September 30, 2024 | 984.62M |
| September 27, 2024 | 919.54M |
| September 26, 2024 | 898.99M |
| September 25, 2024 | 848.75M |
| September 24, 2024 | 881.86M |
| September 23, 2024 | 821.34M |
| September 20, 2024 | 833.90M |
| September 19, 2024 | 783.67M |
| September 18, 2024 | 758.55M |
| September 17, 2024 | 748.27M |
| September 16, 2024 | 753.98M |
| September 13, 2024 | 761.97M |
| September 12, 2024 | 779.10M |
| September 11, 2024 | 757.40M |
| September 10, 2024 | 748.27M |
| September 09, 2024 | 752.84M |
| September 06, 2024 | 748.27M |
| September 05, 2024 | 783.67M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
209.46M
Minimum
Dec 11 2023
2.403B
Maximum
Aug 17 2020
813.02M
Average
749.23M
Median
Enterprise Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Opthea Ltd | 544.62M |
| Immuron Ltd | 3.484M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.92M |
| Revenue (Quarterly) | 2.139M |
| Total Expenses (Quarterly) | 20.88M |
| EPS Diluted (Quarterly) | 77.55 |